Early Phase 1 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have signed a consent form agreeing to take part in the trial
- People who are 18 years of age or older at the time of signing consent
- People whose general health and ability to carry out daily activities is rated at a good to fully active level (a measure doctors use called ECOG score 0 or 1)
- People who have been diagnosed with a specific type of lung cancer (non-small cell lung cancer, Stage II–III) confirmed by laboratory testing, and who have already had surgery to remove the lung tumour
- People who do not have another currently active cancer
- People who received treatment before their surgery, such as chemotherapy, immunotherapy, or other therapies, are eligible
- People who are willing and able to follow all parts of the trial plan
- People who are receiving standard care treatments as decided by their treating doctor and hospital
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who previously had to stop chemotherapy, immunotherapy, or targeted therapy due to a serious side effect rated as severe or worse (Grade 3 or higher)
- People who have been diagnosed with another primary cancer within the past 2 years that their enrolling doctor considers to still be active
- People who have known active cancer that has spread to the brain or the lining around the brain or spinal cord
- People who have a history of lung inflammation (not caused by infection) that needed steroid treatment, or who currently have lung inflammation
- People who have a history of a condition involving scarring or inflammation of the lung tissue (interstitial lung disease)
- People who have any other health condition, past or current, or abnormal test results that the treating doctor believes could interfere with the trial results, affect the person's ability to take part for the full duration, or would not be in the person's best interest
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 732-235-2465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of Circulating Tumor DNA (ctDNA) Post-Surgery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.